Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Stock Short Interest Report for October

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 300,482 shares, a growth of 109.3% from the September 30th total of 143,564 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 92,193 shares, the short-interest ratio is presently 3.3 days.

Analyst Upgrades and Downgrades

Separately, Loop Capital set a $1.00 price objective on shares of Xtant Medical in a research note on Wednesday, September 2nd. Two research analysts have rated the stock with a Buy rating. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $1.00.

Xtant Medical Trading Down 3.5%

Xtant Medical stock traded down $0.01 during trading on Friday, hitting $0.28. The company had a trading volume of 44,518 shares, compared to its average volume of 100,139. The company has a current ratio of 2.16, a quick ratio of 1.05 and a debt-to-equity ratio of 0.18. The stock has a market cap of $39.31 million, a price-to-earnings ratio of -3.50 and a beta of -0.20. The company’s 50 day simple moving average is $0.33 and its 200-day simple moving average is $0.46. Xtant Medical has a 1-year low of $0.27 and a 1-year high of $0.95.

Xtant Medical (NYSEAMERICAN:XTNT) last released its earnings results on Tuesday, August 11th. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.05). The business had revenue of $23.03 million for the quarter, compared to analyst estimates of $24.88 million. Xtant Medical had a negative return on equity of 23.45% and a negative net margin of 10.17%.

Institutional Investors Weigh In On Xtant Medical

A hedge fund recently bought a new stake in Xtant Medical stock. AWM Investment Company Inc. acquired a new stake in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,976,910 shares of the medical device company’s stock, valued at approximately $2,516,000. AWM Investment Company Inc. owned about 4.26% of Xtant Medical as of its most recent SEC filing. 69.33% of the stock is owned by hedge funds and other institutional investors.

About Xtant Medical

Xtant Medical Holdings, Inc is a medical technology company focused on developing, manufacturing and distributing orthobiologic and spinal implant products. Its offerings are designed to support bone growth, spinal fusion and the repair or reconstruction of musculoskeletal tissue.

The company’s product portfolio includes biologic materials such as allograft and other regenerative tissue products, along with spinal implants, interbody devices, fixation systems and related surgical instruments.